Parameters for image-map-2:{}
University of New Haven logo
Menacherry, Stanley (full)
Stanley
Menacherry
Ph.D.
Professional in Residence
Tagliatela College of Engineering
Chemistry & Chemical Engineering
203-479-4177
BCKM320
Buckman Hall
Biography

    Dr. Menacherry started teaching at the University of New Haven in August 2011 as adjunct in Chemistry. Since January 2013, he has been serving as a Professional In Residence at the university. Dr Menacherry is an entrepreneur, having co-founded two companies: Northeast Bioanalytical laboratories, Hamden, CT which is engaged in quantitation of drugs and metabolites from specimens obtained from clinical trials, and Computer Hospital Inc.,West Haven, CT which is engaged in developing mobile computing for clinical trials and patient enrollment. Prior to starting his own business, Dr Menacherry was employed by major pharma: Abbott Laboratories, IL and Bayer Pharmaceuticals, CT. He was a group leader in the pharmacokinetics and drug metabolism departments of these companies.

    Dr. Menacherry’s research interests are in the field of pharmaceutical chemistry, toxicology, and applications of LC tandem mass spectrometry. His current projects include detection of drugs and metabolites in blood and tissue and the development of databases for tracking laboratory data. 

Academic Credentials

    Education 

    Ph.D. Analytical Chemistry, Emory University, Atlanta, GA.               1991

    MBA University of New Haven New Haven, CT.                                2000

    MS (Population Sciences), Bombay University (India)                         1985

    Certificate in Pharmacokinetics. University of Arizona (Tucson)         1995

    Diploma in Statistical Quality Control (Indian Statistical Inst.)            1980

    Publications

    1.      Quantitation of TNP-470 And Its Metabolites In Human Plasma: Sample Handling, Assay Performance And Stability.  Ong VS; Stamm GE; Menacherry S; Chu S, J Chromatogr B Biomed Sci Appl, 1998, 710 (1-2):173-82.

    2.      Hui YH, Marsh KC, Menacherry S. Analytical method development for the simultaneous quantitation of dexmedetomidine and three potential metabolites in plasma.  J Chromatogr A. 1997 Feb 21;762(1-2):281-91.

    3.      Ex Vivo Inhibition Of Beta-Thromboglobulin Release Following Administration To Man Of ABT-299, A Novel Prodrug Of A Potent Platelet Activating Factor Antagonist.  Albert DH; Magoc TJ; Menacherry SD; Morgan DW; Sun E; Reyes AE; Kleinert HD; Carter GW; Summers JB, Inflamm Res, 1997, 46(7):272-7.

    4.      Pharmacokinetics Of Sertindole And Dehydrosertindole In Volunteers With Normal Or Impaired Renal Function. Wong SL; Menacherry S; Mulford D; Schmitz PJ; Locke C; Granneman GR, Eur J Clin Pharmacol, 1997, 52(3):223-7.

    5.      Effect of Renal Impairment on the Pharmacokinetics of a New Dopaminergic Selective Anti-Psychotic Compound. S.L. Wong, T. Sebree, S. Menacherry, D. Mulford, P. Linnen, G.R. Granneman Clin. Pharmacol  & Therapeutics, 1996,  59(2), 186.

    6.   Liquid Chromatography Combined with Tandem Mass Spectrometry for the Confirmation of Sarafloxacin in Catfish Tissue. Schilling J.B. , Cepa S.P., Menacherry, S.D.. Bavda L.T., Heard B.M. and Stockwell B.L. Anal. Chem. 1996, 68 (11), 1905-1909.

    7.      Analytical Method Development for the Simultaneous Quantitation of Dexmedetomidine and Three Potential Metabolites in Plasma Using GC/MS with Negative and Positive Ionization. Hui Y.H., Marsh, K.C. and Menacherry S.D.  J. of Chromatography   1997, (A) 762, 281-291.

    8.      A Sensitive And Specific Method For The Assay Of Sertindole And It’s Metabolites In Human Serum Using HPLC With Tandem Mass Spectrometric Detection.  Menacherry, S.D., Stamm, G.E. and Chu S.Y.,  J. Liq. Chrom. & Rel. Technol., 1997, 20 (14), 2241-2257.

    9.      In Vivo Calibration of Microdialysis Probes for  Exogenous Compounds.  Menacherry S., Hubert W. and Justice J. B. Jr.,  Anal. Chem. 1992, 64 (6), 577-583.

    10.    Anomalous Effect of Mazindol on Dopamine Uptake as Measured by In Vivo Voltammetry and Microdialysis.  Ng J., Menacherry S. and Justice J. B. Jr.,  NeuroSci. Letters, 1992, 134 (2), p229-32.

    11.    Analysis of 2DG Autoradiograms using Image-Averaging and Image Differencing Procedures For Systems-Level Description of Neurobehavioral Function Hall W.G., Swithers S.E., Agrawal C.M., Burka N.R., Horner J. and Menacherry S.,  Physiol Behav.  1991 50 (1), 109-119.

    12.    In Vivo Microdialysis with Thermospray Tandem Mass Spectrometry of the Dopamine Uptake Blocker GBR-12909.   Menacherry S. D. and Justice J. B. Jr.  Anal. Chem.  1990, 26, 587-601.

    13.    Differences in the Pharmacokinetics of Cocaine in Naive and Cocaine Experienced Rats. Pan H.T., Menacherry, S. D. and Justice J.B. Jr.,  J. Neurochem. 1990, 56: (4), 1299-1306.

    14.    An Orthogonal Array Experimental Design for Determining Important Factors Influencing the Quality of Activated Carbon during the Manufacturing Process. Menacherry S. Rao S. N., Annals of the Indian Statistical Institute, 1979.

    Courses Taught

            CH 115/116 -  General Chemistry I and II

            CH 117/118 -  General Chemistry I and II Laboratory

            CH 103        -  Introduction to Chemistry